@article{3102769,
    title = "Vitamin D and COVID-19",
    author = "Trovas, G. and Tournis, S.",
    journal = "Vitamins and Hormones",
    year = "2021",
    volume = "20",
    number = "1",
    pages = "207-208",
    publisher = "Springer Science and Business Media Deutschland GmbH",
    doi = "10.1007/s42000-020-00231-9",
    keywords = "vitamin D;  vitamin D, clinical outcome;  coronavirus disease 2019;  disease association;  disease severity;  hospitalization;  human;  immune response;  mortality rate;  Note;  prevalence;  vitamin blood level;  vitamin D deficiency;  vitamin supplementation;  complication;  prevention and control;  vitamin D deficiency, COVID-19;  Humans;  SARS-CoV-2;  Vitamin D;  Vitamin D Deficiency",
    abstract = "Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections. © 2020, Hellenic Endocrine Society."
}